Established in 2006, Polgenix, Inc., is a small biotech company, whose aims encompass two areas: 1. Drug discovery targeting G protein-coupled receptors (GPCRs) to treat common blinding diseases 2. Innovative high-resolution retinal imaging for ophthalmic drug discovery Our Team: Administration: Richard Sutkus, Ph.D., CEO Krzysztof Palczewski, Ph.D., Chief Scientific Officer Vida M. Tripodo, Director of Finance & Administration Science Team: Grazyna Palczewska, M.Sc., M.E., Director of Medical Device Development David Salom, Ph.D., Scientist Wenyu Sun, Ph.D., Scientist Zhiqian Dong, M.D., Ph.D., Research Scientist
View Top Employees from POLGENIX, INC.Website | http://www.polgenixinc.com/ |
Revenue | $1 million |
Employees | 2 (1 on RocketReach) |
Founded | 2006 |
Address | 11000 Cedar Ave Ste 260, Cleveland, Ohio 44106, US |
Phone | (216) 658-4528 |
Fax | (216) 658-4529 |
Technologies | |
Industry | Business Services General, Biotechnology, Business Services, Science and Engineering |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular POLGENIX, INC. employee's phone or email?
The POLGENIX, INC. annual revenue was $1 million in 2023.
Grazyna Palczewska is the Director, Medical Device of POLGENIX, INC..
1 people are employed at POLGENIX, INC..
POLGENIX, INC. is based in Cleveland, Ohio.
The NAICS codes for POLGENIX, INC. are [54171, 541714, 54, 5417, 541].
The SIC codes for POLGENIX, INC. are [873, 87].